National Priority Voucher Program
The FDA has announced the first nine companies to participate in its National Priority Voucher program, which aims to promote novel treatments that benefit the health interests of Americans.
This program includes medications that meet a large, unmet need or reduce downstream health care utilization, as well as those that utilize MFN pricing.
Nine medications are on the initial list of program participants.
The Priority Voucher program is a new initiative at the agency to promote novel treatments that FDA believes will benefit the health interests of Americans.
Author's summary: FDA announces first participants in Priority Voucher program.